Brain Cancer
Cerebral Glioblastoma
Male, 35 years
Patient Internal 777141807
ICD-10 code
C71.8 Malignant Neoplasm of Overlapping Sites of Brain
Diagnosis (Incl. Metastases/Stage) and Year
January 2021
Glioblastoma, WHO Grade IV, ATRX (-), MGMT (-), IDH (+).
Previous Treatment
Surgery, Radiation Therapy, Chemotherapy (Temozolomide).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of Glioblastomas being around 14 months from diagnosis.
Treatment Provided
Autologous DCV (11 doses) and CIK (16 doses) over a period of 17 months.
Patient Survival/Condition and Year
Date of Review: 17/02/2024
The patient has survived for 31 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy and Radiation Therapy, has extended patient survival by an estimate of around 18 months.
